SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001615219-24-000084
Filing Date
2024-11-01
Accepted
2024-11-01 17:04:12
Documents
5
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A slrx-2023proxystatement.htm DEF 14A 402361
2 image1a.jpg GRAPHIC 20005
3 image2a.jpg GRAPHIC 19680
4 image3a.jpg GRAPHIC 117069
5 imagea.jpg GRAPHIC 149181
  Complete submission text file 0001615219-24-000084.txt   825313
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36812 | Film No.: 241419908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)